Skip to content
The Kids Research Institute Australia logo
Donate

Discover . Prevent . Cure .

Research

Severe adverse events following benzathine penicillin G injection for rheumatic heart disease prophylaxis

Jonathan Rosemary Carapetis AM Wyber AM MBBS FRACP FAFPHM PhD FAHMS MBChB MPH FRACGP PhD Executive Director; Co-Head, Strep A Translation; Co-Founder of REACH Senior Research Fellow 08 6319 1000 contact@thekids.org.au Institute Director; Head, Strep

Research

RHD Screening Program - GE Healthcare

Jonathan Carapetis AM AM MBBS FRACP FAFPHM PhD FAHMS Executive Director; Co-Head, Strep A Translation; Co-Founder of REACH 08 6319 1000 contact@thekids.org.au Institute Director; Head, Strep A Translation; Co-Founder of REACH Professor Carapetis is

Research

RHD Action

Rosemary Sophie Jonathan Wyber La Vincente Carapetis AM MBChB MPH FRACGP PhD BPsych (Hons) MAppEpi PhD AM MBBS FRACP FAFPHM PhD FAHMS Senior Research Fellow Rheach Deputy Director Executive Director; Co-Head, Strep A Translation; Co-Founder of REACH

Research

Reach: to stop rheumatic heart disease

Rosemary Sophie Jonathan Wyber La Vincente Carapetis AM MBChB MPH FRACGP PhD BPsych (Hons) MAppEpi PhD AM MBBS FRACP FAFPHM PhD FAHMS Senior Research Fellow Rheach Deputy Director Executive Director; Co-Head, Strep A Translation; Co-Founder of REACH

Research

Pharmacokinetics of intramuscular versus subcutaneous administration of Benzathine Penicillin G

Jonathan Rosemary Carapetis AM Wyber AM MBBS FRACP FAFPHM PhD FAHMS MBChB MPH FRACGP PhD Executive Director; Co-Head, Strep A Translation; Co-Founder of REACH Senior Research Fellow 08 6319 1000 contact@thekids.org.au Institute Director; Head, Strep